Jing Liang

Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.

2 Subunit-Containing GABA Receptor Subtypes Are Upregulated and Contribute to Alcohol-Induced Functional Plasticity in the Rat Hippocampus.

Role of GABA receptors in alcohol use disorders suggested by chronic intermittent ethanol (CIE) rodent model.

Inhaled nicotine equivalent to cigarette smoking disrupts systemic and uterine hemodynamics and induces cardiac arrhythmia in pregnant rats.

Single Ethanol Withdrawal Regulates Extrasynaptic δ-GABA Receptors Via PKCδ Activation.

Chronic intermittent nicotine delivery via lung alveolar region-targeted aerosol technology produces circadian pharmacokinetics in rats resembling human smokers.

Flavonoids isolated from Tibetan medicines, binding to GABA receptor and the anticonvulsant activity.

Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism.

Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety.

A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice.

Social Isolation Induces Neuroinflammation And Microglia Overactivation, While Dihydromyricetin Prevents And Improves Them.

Social isolation induces neuroinflammation and microglia overactivation, while dihydromyricetin prevents and improves them.

Dihydromyricetin improves social isolation-induced cognitive impairments and astrocytic changes in mice.

Social isolation induces succinate dehydrogenase dysfunction in anxious mice.